| Literature DB >> 35897463 |
Mireia Julià1,2,3, Fabrizio Méndez-Rivero1, Álex Gómez-Gómez4, Óscar J Pozo4, Mireia Bolíbar1,5.
Abstract
Precarious employment has been highlighted as a social determinant of health, given, among others, to its alleged association with chronic stress. However, few studies have been conducted analyzing such association, using both perceived stress indicators and biological markers. Accordingly, the present study analyzed the association of multidimensional (6 dimensions) precarious employment scale with perceived stress and 23 markers of adrenal and gonadal hormone production, including cortisol. The sample consisted of 255 salaried workers from Barcelona (125 men, 130 women) aged 25-60. OLS regression models stratified by sex were conducted. Results demonstrated that precarious employment increased the probabilities of having perceived stress in both sexes. In addition, the production of adrenal hormones among men is associated with precarious wages and among women with precarious contracts ("Temporariness", "Disempowerment", and "Rights" dimensions). Therefore, precarious employment could be embodied by workers, altering their perceived well-being and physiological characteristics. Differences between men and women in the physiological effect of precarious employment could express not just the biochemical differences inherent to biological sex, but also the social construction of gender identities, positions and roles in society and family, as well as gender inequalities in the labour market.Entities:
Keywords: chronic stress; cortisol; gender; precarious employment; social determinants of health
Mesh:
Year: 2022 PMID: 35897463 PMCID: PMC9330896 DOI: 10.3390/ijerph19159099
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Characteristics of the study population stratified by sex. Precarious Employment and Stress Study sample, 2020. [SD = Standard deviation].
| Men ( | Women ( | ||||
|---|---|---|---|---|---|
| Mean | SD 1 | Mean | SD 1 | ||
| Age (years) | 41.68 | 9.84 | 42.75 | 9.79 | 0.383 |
| Body mass index (BMI) (kg/m2) | 25.34 | 3.59 | 24.75 | 4.31 | 0.233 |
| Precarious employment (EPRES) | |||||
| Global scale | 1.04 | 0.56 | 1.02 | 0.55 | 0.797 |
| Temporarines | 1.27 | 1.20 | 1.04 | 1.13 | 0.124 |
| Wages | 1.13 | 0.93 | 1.44 | 1.06 | 0.013 |
| Rights | 0.45 | 0.76 | 0.38 | 0.64 | 0.445 |
| Disempowerment | 1.40 | 1.16 | 1.26 | 1.16 | 0.341 |
| Excercise of rights | 0.62 | 0.77 | 0.69 | 0.82 | 0.523 |
| Vulnerability | 1.18 | 0.98 | 1.12 | 0.96 | 0.625 |
| Perceived Stress Scale (PSS) | 22.50 | 7.59 | 26.12 | 7.43 | 0.000 |
| Adrenal and gonadal steroids (ng/mg) | |||||
| Cortisol | 12.42 | 18.90 | 9.33 | 7.35 | 0.090 |
| 20αDHF | 0.99 | 1.15 | 0.99 | 0.96 | 0.977 |
| 20βDHF | 5.67 | 4.19 | 4.46 | 2.71 | 0.007 |
| 20αDHE | 10.20 | 8.42 | 9.05 | 6.41 | 0.223 |
| 20βDHE | 7.48 | 5.70 | 5.37 | 3.26 | 0.000 |
| Cortisone | 33.89 | 18.37 | 26.88 | 17.20 | 0.002 |
| Cortolone | 8.73 | 3.94 | 7.09 | 3.08 | 0.000 |
| 11-Dehidrocorticosterone (A) | 2.99 | 1.59 | 2.54 | 1.57 | 0.023 |
| Testosterone | 2.07 | 2.10 | 3.08 | 24.36 | 0.638 |
| Androstenedione (AED) | 5.43 | 3.07 | 3.91 | 2.90 | 0.000 |
| Progesterone | 232.62 | 1511.24 | 27.01 | 32.96 | 0.130 |
| 20αDHF/20βDHF | 0.17 | 0.17 | 0.20 | 0.10 | 0.048 |
| 20αDHE/20βDHE | 1.38 | 0.33 | 1.65 | 0.39 | 0.000 |
| Cortisone/11-Dehydrocorticosterone (E/A) | 13.01 | 7.09 | 12.97 | 8.82 | 0.968 |
| Cortisol/Cortisone | 0.36 | 0.45 | 0.36 | 0.24 | 0.901 |
| %Cortisol | 15.12 | 9.25 | 16.04 | 6.42 | 0.359 |
| %Cortisone | 50.54 | 10.29 | 48.51 | 9.16 | 0.097 |
| %20αDHF | 1.23 | 0.76 | 1.61 | 0.82 | 0.000 |
| %20βDHF | 8.18 | 2.74 | 8.24 | 2.15 | 0.843 |
| %20αDHE | 14.30 | 3.92 | 15.85 | 4.39 | 0.003 |
| %20βDHE | 10.63 | 2.80 | 9.75 | 2.18 | 0.006 |
| 20αDHF/Cortisol | 0.09 | 0.06 | 0.11 | 0.08 | 0.030 |
| 20βDHF/Cortisol | 0.65 | 0.31 | 0.59 | 0.28 | 0.074 |
1 SD = Standard deviation.
Linear regression coefficients and 95% confidence intervals (CI) for EPRES global scale predicting Production of Adrenal and Gonadal steroids and PSS, adjusted for control variables and stratified by sex. Precarious Employment and Stress Study sample, 2020.
| Outcome 1 | Men ( | Women ( | ||
|---|---|---|---|---|
| β | 95% CI | β | 95% CI | |
| Perceived Stress Scale | 4.82 ** | (2.56–7.08) | 5.49 ** | (3.35–7.63) |
| Adrenal and gonadal steroids | ||||
| Cortisol | −0.00 | (−0.27–0.27) | −0.05 | (−0.27–0.17) |
| 20αDHF | 0.08 | (−0.25–0.42) | 0.11 | (−0.15–0.37) |
| 20βDHF | 0.06 | (−0.14–0.26) | 0.11 | (−0.05–0.27) |
| 20αDHE | 0.04 | (−0.15–0.24) | 0.18 | (−0.00–0.35) |
| 20βDHE | 0.05 | (−0.14–0.25) | 0.18 * | (0.02–0.34) |
| Cortisone | 0.04 | (−0.14–0.22) | 0.12 | (−0.05–0.29) |
| Cortolone | 0.02 | (−0.16–0.19) | 0.01 | (−0.16–0.17) |
| 11-dehydrocorticosterone (A) | 0.13 | (−0.04–0.29) | 0.18 * | (0.01–0.36) |
| Testosterone | 0.16 | (−0.06–0.38) | 0.08 | (−0.28–0.45) |
| Androstenedione (AED) | 0.09 | (−0.08–0.27) | 0.16 | (−0.04–0.37) |
| Progesterone | 0.14 | (−0.53–0.80) | 0.12 | (−0.43–0.67) |
| 20αDHF/20βDHF | 0.01 | (−0.22–0.24) | 0.00 | (−0.16–0.16) |
| 20αDHE/20βDHE | −0.01 | (−0.08–0.06) | −0.00 | (−0.07–0.06) |
| Cortisone/11-dehydrocorticosterone (E/A) | −0.08 | (−0.26–0.10) | −0.07 | (−0.27–0.14) |
| Cortisol/Cortisone | −0.05 | (−0.25–0.16) | −0.17 * | (−0.33–−0.00) |
| %Cortisol | −0.04 | (−0.18–0.10) | −0.16 ** | (−0.28–−0.05) |
| %Cortisone | 0.01 | (−0.07–0.09) | 0.01 | (−0.06–0.08) |
| %20αDHF | 0.04 | (−0.19–0.28) | 0.00 | (−0.17–0.17) |
| %20βDHF | 0.02 | (−0.08–0.13) | −0.00 | (−0.08–0.08) |
| %20αDHE | 0.01 | (−0.07–0.09) | 0.07 | (−0.02–0.15) |
| %20βDHE | 0.01 | (−0.07–0.10) | 0.07 * | (0.00–0.14) |
| 20αDHF/Cortisol | 0.09 | (−0.16–0.34) | 0.16 | (−0.02–0.34) |
| 20βDHF/Cortisol | 0.06 | (−0.13–0.25) | 0.16 * | (0.02–0.30) |
1 All outcomes have been transformed into logarithms to correct skewness. ** p < 0.01, * p < 0.05.
Linear regression coefficients and 95% confidence intervals (CI) for Production of Adrenal and Gonadal steroids and EPRES dimensions (Temporariness, Vulnerability, Wages, Rights, Disempowerment and Exercise of rights), adjusted for control variables and stratified by sex. Precarious Employment and Stress Study sample, 2020.
| Temporariness | Vulnerability | Wages | Rights | Disempowerment | Exercise Rights | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3a. Men. N = 125 | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI | β | 95% CI |
| PSS | −0.04 | (−0.17–0.09) | 1.78 ** | (0.48–3.08) | 0.19 * | (0.04–0.35) | 0.06 | (−0.14–0.25) | −0.04 | (−0.17–0.08) | −0.09 | (−0.28–0.10) |
| Adrenal and gonadal steroids 1 | ||||||||||||
| Cortisol | −0.07 | (−0.23–0.09) | −0.06 | (−0.21–0.09) | 0.32 ** | (0.13–0.51) | 0.12 | (−0.11–0.36) | −0.04 | (−0.19–0.12) | −0.01 | (−0.25–0.23) |
| 20αDHF | −0.03 | (−0.13–0.06) | −0.05 | (−0.23–0.14) | 0.22 ** | (0.12–0.33) | 0.06 | (−0.08–0.20) | −0.01 | (−0.11–0.08) | −0.03 | (−0.17–0.11) |
| 20βDHF | −0.04 | (−0.13–0.05) | −0.05 | (−0.16–0.06) | 0.20 ** | (0.09–0.31) | 0.07 | (−0.06–0.21) | 0.00 | (−0.09–0.09) | −0.02 | (−0.15–0.12) |
| 20αDHE | −0.04 | (−0.13–0.06) | −0.07 | (−0.18–0.03) | 0.22 ** | (0.11–0.32) | 0.08 | (−0.05–0.22) | 0.00 | (−0.09–0.10) | −0.04 | (−0.18–0.10) |
| 20βDHE | −0.06 | (−0.14–0.03) | −0.08 | (−0.19–0.03) | 0.16 ** | (0.05–0.26) | 0.04 | (−0.09–0.17) | 0.03 | (−0.06–0.11) | −0.03 | (−0.15–0.10) |
| Cortolone | 0.02 | (−0.06–0.10) | −0.02 | (−0.12–0.08) | 0.15 ** | (0.06–0.24) | 0.11 | (−0.00–0.23) | 0.01 | (−0.07–0.08) | 0.05 | (−0.06–0.17) |
| 11-dehydrocorticosterone (A) | 0.04 | (−0.07–0.14) | −0.04 | (−0.13–0.05) | 0.19 ** | (0.06–0.31) | 0.14 | (−0.01–0.29) | 0.03 | (−0.08–0.13) | −0.03 | (−0.18–0.13) |
| Testosterone | −0.03 | (−0.12–0.05) | −0.04 | (−0.16–0.08) | 0.05 | (−0.06–0.15) | 0.03 | (−0.09–0.15) | 0.09 * | (0.01–0.17) | 0.02 | (−0.11–0.14) |
| Androstenedione (AED) | 0.02 | (−0.30–0.34) | 0.02 | (−0.08–0.11) | 0.04 | (−0.35–0.43) | 0.10 | (−0.37–0.57) | −0.12 | (−0.44–0.19) | 0.47 * | (0.00–0.93) |
| %Cortisone | −0.02 | (−0.13–0.09) | 0.01 | (−0.03–0.06) | 0.14 * | (0.00–0.27) | 0.08 | (−0.09–0.24) | −0.04 | (−0.15–0.07) | 0.02 | (−0.14–0.19) |
| 3b. Women. N = 130 | ||||||||||||
| PSS | 0.06 | (−0.06–0.18) | 2.07 ** | (0.80–3.34) | −0.05 | (−0.17–0.06) | −0.03 | (−0.22–0.16) | −0.07 | (−0.17–0.03) | −0.06 | (−0.21–0.08) |
| Adrenal and gonadal steroids 1 | ||||||||||||
| Cortisol | 0.14 * | (0.00–0.28) | 0.04 | (−0.08–0.17) | 0.00 | (−0.13–0.14) | 0.04 | (−0.19–0.27) | −0.04 | (−0.16–0.08) | 0.02 | (−0.15–0.19) |
| 20βDHF | 0.12 * | (0.02–0.21) | 0.07 | (−0.02–0.16) | 0.03 | (−0.06–0.13) | 0.09 | (−0.06–0.25) | −0.00 | (−0.08–0.08) | 0.05 | (−0.06–0.17) |
| 20αDHE | 0.10 * | (0.01–0.18) | 0.06 | (−0.04–0.16) | 0.03 | (−0.06–0.11) | 0.09 | (−0.05–0.23) | 0.02 | (−0.06–0.09) | 0.06 | (−0.05–0.16) |
| Cortolone | 0.11 * | (0.02–0.21) | −0.02 | (−0.11–0.07) | 0.08 | (−0.01–0.17) | 0.20 * | (0.05–0.35) | −0.01 | (−0.09–0.07) | 0.07 | (−0.05–0.18) |
| 20αDHE/20βDHE | −0.08 | (−0.19–0.03) | −0.01 | (−0.05–0.03) | −0.10 * | (−0.21–−0.00) | −0.20 * | (−0.37–−0.02) | 0.09 | (−0.01–0.18) | −0.02 | (−0.16–0.11) |
| Cotisone/11-dehydrocorticosterone (E/A) | 0.02 | (−0.06–0.11) | 0.03 | (−0.08–0.14) | −0.03 | (−0.11–0.06) | −0.03 | (−0.18–0.11) | −0.14 ** | (−0.22–−0.07) | −0.10 | (−0.21–0.00) |
| Cortisol/Cortisone | −0.01 | (−0.07–0.06) | −0.01 | (−0.10–0.08) | −0.04 | (−0.10–0.02) | −0.07 | (−0.17–0.04) | −0.09 ** | (−0.14–−0.04) | −0.09 * | (−0.16–−0.01) |
| %Cortisol | −0.03 | (−0.07–0.00) | −0.01 | (−0.08–0.05) | −0.02 | (−0.05–0.02) | −0.03 | (−0.09–0.02) | 0.05 ** | (0.02–0.08) | 0.02 | (−0.03–0.06) |
| %20βDHF | 0.05 * | (0.00–0.09) | 0.02 | (−0.03–0.06) | 0.04 * | (0.00–0.09) | 0.06 | (−0.02–0.13) | −0.02 | (−0.06–0.02) | 0.03 | (−0.03–0.08) |
| %20αDHE | 0.03 | (−0.01–0.07) | 0.00 | (−0.05–0.05) | 0.04 * | (0.00–0.07) | 0.05 | (−0.00–0.11) | −0.00 | (−0.04–0.03) | 0.03 | (−0.01–0.07) |
| 20αDHF/Cortisol | 0.00 | (−0.08–0.08) | −0.00 | (−0.10–0.10) | 0.06 | (−0.02–0.13) | 0.07 | (−0.06–0.20) | 0.07 ** | (0.01–0.14) | 0.08 | (−0.01–0.18) |
| 20βDHF/Cortisol | 0.00 | (−0.08–0.08) | 0.03 | (−0.05–0.11) | 0.06 | (−0.02–0.13) | 0.07 | (−0.06–0.20) | 0.07 ** | (0.01–0.14) | 0.08 | (−0.01–0.18) |
1 All outcomes have been transformed into logarithms to correct skewness. ** p < 0.01, * p < 0.05.